Liver-derived mesenchymal stem cells increase cancer cell plasticity through TGF-beta pathway activation in a hepatocellular carcinoma spheroid co-culture model

Background and Aims: Mesenchymal stem cells (MSCs) play a highly debated role in cancer. Potent anti- and pro-tumour properties have been shown in vitro and in vivo, depending on the tumour studied and the MSC used. Here, we investigate the interaction between liver-derived MSC and hepatocellular carcinoma cells (HCC), with a focus on cell proliferation, invasiveness and gene expression. We postulate that their shared hepatic origin may provide unique insights into the potential implication of MSCs in carcinogenesis. Method: We developed a 3D bi-cellular spheroid model comprised of Human Adult Liver Progenitor Cells (HALPC), liver-derived MSC previously described in our laboratory, and one of three human HCC cell lines (HuH7, HepG2, Hep3B). Cancer cell proliferation was studied through spheroid growth follow-up and Ki67 immunostaining using light sheet fluorescence microscopy. Cancer cell invasiveness was investigated using transwell and spheroid invasion assays. RNA sequencing was conducted on HALPC and cancer cells from control and co-culture spheroids, separated by fluorescence-activated cell sorting. Results: HCC 3D co-culture with HALPC resulted in a dose-dependent inhibition of spheroid growth. At 25 days post-formation, the volume of control spheroids was up to 70 times larger compared to 50:50 co-culture spheroids (Figure 1.A). This difference in spheroid size was associated with a reduction of up to 66% in Ki67-positive cells in co-culture conditions (p = 4.6x10-5) (Figure 1.B). Invasion studies demonstrated the induction of an invasive phenotype in the cancer cell lines when co-cultured with HALPC (Figure 2). Comprehensive transcriptomic analysis showed substantial changes in expression levels, with 2002 and 3601 up- or downregulated genes in HALPC and cancer cells, respectively (| logFC | > 1 ; p adj. < 0.05). In co-cultured cancer cells, an increased cell plasticity was observed, with induction of a partial epithelial-mesenchymal transition and hepatocyte-to-cholangiocyte trans-differentiation. Co-cultured HALPC showed an increase in cancer associated-fibroblast (CAF) transcriptomic signature. These changes occur simultaneously with the activation of the TGF-beta pathway at the transcriptomic level in both cell types. Conclusion: We demonstrate that liver-derived MSCs decrease the proliferation and induce the invasiveness of several human HCC cell lines. This is associated with the induction of cancer cell plasticity, the increase in the CAF signature of HALPC, and the overall activation of the TGF-beta pathway in both cell types at the transcriptomic level. These findings support the potential role of organ-resident MSCs in HCC carcinogenesis. Ongoing work aims to confirm the transcriptomic findings at the protein level, verify the implication of TGF-beta in the acquired phenotype through pathway inhibition and validate the obtained results in vivo, using an orthotopic xenogeneic bioluminescent mouse model.

Affiliations

Citations

APA
Chicago
FWB

de Bodt, G., Ravau, J., Evraerts, J., Stephenne, X., Najimi, M., & Sokal, E. (2025). Liver-derived mesenchymal stem cells increase cancer cell plasticity through TGF-beta pathway activation in a hepatocellular carcinoma spheroid co-culture model. 18th CTRMS International Congress (Cell Transplant and Regenerative Medicine), Tokyo, Japan. https://hdl.handle.net/2078.5/259434